Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
5,805
+502
+9% +$108K 0.76% 24
2026
Q1
$1.15M Buy
5,303
+903
+21% +$200K 0.68% 31
2025
Q4
$1.01M Buy
+4,400
New +$1M 0.63% 36

Other funds holding ABBV

Cyr Financial's ABBV Position: Q2 2026 in Review

Cyr Financial increased its AbbVie (ABBV) stake by 9.5% in Q2 2026, buying an estimated $108K and bringing the position to 5,805 shares worth $1.46M. The position accounts for 0.76% of the portfolio, ranked #24.

Cyr Financial first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cyr Financial held 5,805 shares of AbbVie worth $1.46M as of Q2 2026.
  • Cyr Financial bought 502 AbbVie shares in Q2 2026, an estimated $108K.
  • AbbVie made up 0.76% of Cyr Financial's portfolio in Q2 2026, its #24 holding.
  • Cyr Financial first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cyr Financial's 13F filing for Q2 2026, filed 20 Jul 2026.